Login / Signup

Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.

Jonathon W SenefeldPatrick W JohnsonKatie L KunzeEvan M BlochNoud van HelmondMichael A GolafsharStephen A KlassenAllan M KlompasMatthew A SextonJuan C Diaz SotoBrenda J GrossmanAaron A R TobianRuchika GoelChad C WigginsKatelyn A BrunoCamille M van BuskirkJames R StubbsJeffrey Lawrence WintersArturo CasadevallNigel S PanethBeth H ShazMolly M PetersenBruce S SachaisMatthew R BurasMikolaj A WieczorekBenjamin RussonielloLarry J DumontSarah E BakerRalph R VassalloJohn R A ShepherdPampee P YoungNicole C VerdunPeter W MarksN Rebecca HaleyRobert F ReaLouis KatzVitaly HerasevichDan A WaxmanEmily R WhelanAviv BergmanAndrew J ClayburnMary Kathryn GrabowskiKathryn F LarsonJuan G RipollKylie J AndersenMatthew N P VogtJoshua J DennisRiley J RegimbalPhilippe R BauerJanis E BlairZachary A BuchholtzMichaela C PletschKatherine WrightJoel T GreenshieldsMichael J JoynerR Scott WrightRickey E CarterDeLisa Fairweather
Published in: PLoS medicine (2021)
ClinicalTrials.gov NCT#: NCT04338360.
Keyphrases
  • quality improvement
  • coronavirus disease
  • sars cov